A Biochemical Method for Assessing the Neurotoxic Effects of Misonidazole in the Rat

Overview

Journal Br J Cancer

Specialty Oncology

Date 1980 Dec 1

PMID 7459223

Citations 7

Authors

G P Rose

A J Dewar

I J Stratford

Affiliations

Soon will be listed here.

Abstract

A proven biochemical method for assessing chemically induced neurotoxicity has been applied to the study of the toxic effects of misonidazole (MISO) in the rat. This involves the fluorimetric measurement of beta-glucuronidase and beta-galactosidase activities in homogenates of rat nervous tissue. The tissues analysed were sciatic/posterior tibial nerve (SPTN) cut into 4 sections, trigeminal ganglia and cerebellum. MISO administered i.p. to Wistar rats in doses greater than 300 mg/kg/day for 7 consecutive days produced maximal increases in both beta-glucuronidase and beta-galactosidase activities in th SPTN at 4 weeks (140-180% of control values). The highest increases were associated with the most distal secretion of the nerve. Significant enzyme-activity changes were also found in the trigeminal ganglia and cerebellum of MISO-dosed rats. The greatest activity occurred 4-5 weeks after dosing, and was dose-related. It is concluded that, in the rat, MISO can produce biochemical changes consistent with a dying-back peripheral neuropathy, and biochemical changes suggestive of cerebellar damage. This biochemical approach would appear to offer a convenient quantitative method for the detection of neurotoxic effects of other potential radio-sensitizing drugs.

Citing Articles

Synthesis, characterization, Hirshfeld surface analysis, antioxidant and selective β-glucuronidase inhibitory studies of transition metal complexes of hydrazide based Schiff base ligand.

Farzia , Rehman S, Ikram M, Khan A, Khan R, Sinnokrot M Sci Rep. 2024; 14(1):515.

PMID: 38177189 PMC: 10766943. DOI: 10.1038/s41598-023-49893-6.

Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Awolade P, Cele N, Kerru N, Gummidi L, Oluwakemi E, Singh P Eur J Med Chem. 2019; 187:111921.

PMID: 31835168 PMC: 7111419. DOI: 10.1016/j.ejmech.2019.111921.

Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Wardman P Br J Radiol. 2018; 92(1093):20170915.

PMID: 29303355 PMC: 6435051. DOI: 10.1259/bjr.20170915.

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.

Clarke C, DAWSON K, SHELDON P Br J Cancer. 1982; 45(4):582-7.

PMID: 7073948 PMC: 2010990. DOI: 10.1038/bjc.1982.95.

Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.

Edwards M, Powers S, Baringer R, JEWETT D, Bolger C, Phillips T J Neurooncol. 1983; 1(2):115-23.

PMID: 6678963 DOI: 10.1007/BF00182956.

References

Robins E, Fisher H, LOWE I . Quantitative histochemical studies of the morphogenesis of the cerebellum. II. Two beta-glycosidases. J Neurochem. 1961; 8:96-104. DOI: 10.1111/j.1471-4159.1961.tb13530.x. View

Dewar A, Barron G, Reading H . The effect of retinol and acetylsalicylic acid on the release of lysosomal enzymes from rat retina in vitro. Exp Eye Res. 1975; 20(1):63-72. DOI: 10.1016/0014-4835(75)90108-6. View

Urtasun R, Band P, Chapman J, Rabin H, Wilson A, Fryer C . Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology. 1977; 122(3):801-4. DOI: 10.1148/122.3.801. View

Hirst D, Vojnovic B, Stratford I, Travis E . The effect of the radiosensitizer misonidazole on motor nerve conduction velocity in the mouse. Br J Cancer Suppl. 1978; 3:237-41. PMC: 2149369. View

Dische S . Radiosensitizers in the treatment of squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci. 1977; 2(4):403-9. DOI: 10.1111/j.1365-2273.1977.tb01382.x. View

Saunders M, Dische S, Anderson P, Flockhart I . The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. Br J Cancer Suppl. 1978; 3:268-70. PMC: 2149393. View

HOLLINGER D, Rossiter R . Chemical studies of peripheral nerve during wallerian degeneration. V. B-Glucuronidase. Biochem J. 1952; 52(4):659-63. PMC: 1198076. DOI: 10.1042/bj0520659. View

CAVANAGH J . Peripheral neuropathy caused by chemical agents. CRC Crit Rev Toxicol. 1973; 2(3):365-417. DOI: 10.3109/10408447309082021. View

Hirst D, Vojnovic B, Hobson B . Changes in nerve conduction velocity in the mouse after acute and chronic administration of nitroimidazoles. Br J Cancer. 1979; 39(2):159-67. PMC: 2009849. DOI: 10.1038/bjc.1979.26. View

10.

Scharer K . [Selective alterations of Purkinje cells in the dog after oral administration of high doses of nitroimidazole derivatives (author's transl)]. Verh Dtsch Ges Pathol. 1972; 56:407-10. View

11.

Sinha A, Rose S . Compartmentation of lysosomes in neurones and neuropil and a new neuronal marker. Brain Res. 1972; 39(1):181-96. DOI: 10.1016/0006-8993(72)90794-9. View

12.

Kaplan M, Murphy S . Effect of acrylamide on rotarod performance and sciatic nerve -glucuronidase activity of rats. Toxicol Appl Pharmacol. 1972; 22(2):259-68. DOI: 10.1016/0041-008x(72)90176-7. View

13.

Coxon A, Pallis C . Metronidazole neuropathy. J Neurol Neurosurg Psychiatry. 1976; 39(4):403-5. PMC: 492292. DOI: 10.1136/jnnp.39.4.403. View

14.

Dische S, Saunders M, Lee M, Adams G, Flockhart I . Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977; 35(5):567-79. PMC: 2025511. DOI: 10.1038/bjc.1977.90. View

15.

Conroy P, Von Burg R, PASSALACQUA W, Penney D, Sutherland R . Misonidazole neurotoxicity in the mouse: evaluation of functional, pharmacokinetic, electrophysiologic and morphologic parameters. Int J Radiat Oncol Biol Phys. 1979; 5(7):983-91. DOI: 10.1016/0360-3016(79)90604-7. View

16.

Bowen D, Flack R, Martin R, Smith C, White P, Davison A . Biochemical studies on degenerative neurological disorders. I. Acute experimental encephalitis. J Neurochem. 1974; 22(6):1099-107. DOI: 10.1111/j.1471-4159.1974.tb04342.x. View